By applying single‐crystal X‐ray techniques, it is shown that kaolinite transforms to meta‐kaolin and subsequently to a cubic spinel‐type phase by a process of orderlyrecrystallization. The dimensional and directional relations between the phases are established. On the basis of this information, together with the density of metakaolin, a crystal structure is suggested for metakaolin. X‐ray examination of partly transformed kaolinite provides evidence for some long‐range regularity in the transformation process which is not shown by microcrystalline kaolinite.
This reaction series has been a subject of extensive investigation since the work of Le Chatelier in 1887. Nevertheless, major problems have remained concerned with the nature of metakaolin, the manner in which it transforms into a spinel-type phase and mullite, and the relation of this spinel-type phase to mullite. The present survey brings these problems into sharp focus and provides the necessary historical background for a new approach to their solution.
X-ray diffraction data for the high-temperature phases show that a spinel-type structure develops with marked orientation at about 925°C. This phase is considered to be an aluminum silicon spinel with vacant cation sites. Mullite is thought to be formed by the decomposition of the spinel. Silica is eliminated progressively as metakaolin transforms to the spinel phase and thence to mullite. The X-ray data show variation in the mullite parameters between 1200" and 1400°C. ; at 14OO0C., the composition probably approximates 3A1203 .2Si02. The nature of the intermediate spinel-type phase is discussed in relation to the crystal chemistry of spinels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.